市場調査レポート
商品コード
1310673

経粘膜ドラッグデリバリーのパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業(2023年)

Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

出版日: | 発行: GlobalData | ページ情報: 英文 285 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
経粘膜ドラッグデリバリーのパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業(2023年)
出版日: 2023年06月30日
発行: GlobalData
ページ情報: 英文 285 Pages
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、経粘膜ドラッグデリバリーのパイプライン製品について調査分析し、各開発段階における製品の比較分析や、進行中の臨床試験のデータを含む、包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

  • 経粘膜ドラッグデリバリー - パイプライン製品:開発段階別
  • 経粘膜ドラッグデリバリー - パイプライン製品:セグメント別
  • 経粘膜ドラッグデリバリー - パイプライン製品:地域別
  • 経粘膜ドラッグデリバリー - パイプライン製品:規制経路別
  • 経粘膜ドラッグデリバリー - パイプライン製品:推定承認日別
  • 経粘膜ドラッグデリバリー - 進行中の臨床試験

第4章 経粘膜ドラッグデリバリー - 開発中のパイプライン製品:企業別

  • 経粘膜ドラッグデリバリー企業 - パイプライン製品:開発段階別
  • 経粘膜ドラッグデリバリー - パイプライン製品:開発段階別

第5章 経粘膜ドラッグデリバリーの企業と製品の概要

第6章 経粘膜ドラッグデリバリー - 最近の発展

第7章 付録

図表

List of Tables

List of Tables

  • Transmucosal Drug Delivery - Pipeline Products by Stage of Development
  • Transmucosal Drug Delivery - Pipeline Products by Segment
  • Transmucosal Drug Delivery - Pipeline Products by Territory
  • Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
  • Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
  • Transmucosal Drug Delivery - Ongoing Clinical Trials
  • Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
  • Transmucosal Drug Delivery - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Transmucosal Drug Delivery - Pipeline Products by Stage of Development
  • Transmucosal Drug Delivery - Pipeline Products by Segment
  • Transmucosal Drug Delivery - Pipeline Products by Territory
  • Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
  • Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
  • Transmucosal Drug Delivery - Ongoing Clinical Trials
目次
Product Code: GDME1568EPD

Abstract

GlobalData's Medical Devices sector report, "Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Transmucosal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Transmucosal Drug Delivery device is intended for the localized delivery of medications through a mucous membrane.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transmucosal Drug Delivery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transmucosal Drug Delivery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transmucosal Drug Delivery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Transmucosal Drug Delivery Overview

3 Products under Development

  • 3.1 Transmucosal Drug Delivery - Pipeline Products by Stage of Development
  • 3.2 Transmucosal Drug Delivery - Pipeline Products by Segment
  • 3.3 Transmucosal Drug Delivery - Pipeline Products by Territory
  • 3.4 Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
  • 3.5 Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
  • 3.6 Transmucosal Drug Delivery - Ongoing Clinical Trials

4 Transmucosal Drug Delivery - Pipeline Products under Development by Companies

  • 4.1 Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
  • 4.2 Transmucosal Drug Delivery - Pipeline Products by Stage of Development

5 Transmucosal Drug Delivery Companies and Product Overview

6 Transmucosal Drug Delivery - Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer